🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib/II trial aims to evaluate the safety and preliminary efficacy...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12
Trial ID
NCT07785856
Treatments Being Tested
Single institution study to assess the safety of concurrent Azeliragon with...
Status
Active Not Recruiting
Location
NYU Langone Health
Start Date
2025-02-18
Trial ID
NCT06724926
Treatments Being Tested
A new drug called azeliragon could be used to treat patients with COVID-19 ...
Status
Active Not Recruiting
Location
Rush University
Start Date
2023-05-04
Trial ID
NCT05815485
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of dexamet...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-11-15
Trial ID
NCT05773664
The main goal of this double-blind, randomized, placebo-controlled crossove...
Status
Completed
Location
Medical University of Vienna
Start Date
2025-06-17
Trial ID
NCT07092215
Treatments Being Tested
This is an open label study to determine the safety and preliminary evidenc...
Status
Unknown
Location
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute
Start Date
2023-06-01
Trial ID
NCT05766748
Treatments Being Tested
This is an open label study to determine the safety and preliminary evidenc...
Status
Completed
Location
Hospital del Mar
Start Date
2023-09-05
Trial ID
NCT05635734
Treatments Being Tested
Current research indicates that TTP488 may be a viable agent for the treatm...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-02
Trial ID
NCT00287183
Treatments Being Tested
This is a study to evaluate the efficacy and safety of azeliragon in patien...
Status
Terminated
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02080364
Treatments Being Tested
This is a phase 2 study to evaluate the safety and preliminary evidence of ...
Status
Active Not Recruiting
Location
University of Colorado Anschutz Medical Campus
Start Date
2023-09-12
Trial ID
NCT05986851
Treatments Being Tested